Torray Investment Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,547
Closed -$509K 107
2021
Q4
$509K Sell
5,547
-6,434
-54% -$769K 0.08% 103
2021
Q3
$1.52M Buy
11,981
+130
+1% +$18.9K 0.23% 88
2021
Q2
$1.97M Buy
11,851
+681
+6% +$110K 0.29% 71
2021
Q1
$2.03M Buy
11,170
+1,525
+16% +$354K 0.32% 64
2020
Q4
$1.93M Buy
9,645
+164
+2% +$33.3K 0.32% 64
2020
Q3
$2.08M Sell
9,481
-71
-0.7% -$15K 0.38% 51
2020
Q2
$1.82M Sell
9,552
-2,682
-22% -$470K 0.34% 57
2020
Q1
$1.9M Sell
12,234
-2,998
-20% -$349K 0.42% 52
2019
Q4
$1.27M Buy
15,232
+1,503
+11% +$114K 0.22% 79
2019
Q3
$930K Buy
+13,729
New +$904K 0.1% 84

Other funds holding TDOC

Torray Investment Partners's TDOC Position: Q1 2022 in Review

Torray Investment Partners sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 5,547 shares — an estimated $509K sold.

Torray Investment Partners first reported a position in TDOC in Q3 2019 and held it in 10 quarters. The position peaked at $2.08M in Q3 2020. 679 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Torray Investment Partners reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Torray Investment Partners sold 5,547 Teladoc Health shares in Q1 2022, an estimated $509K.
  • Torray Investment Partners first reported a position in Teladoc Health in Q3 2019 and held it in 10 quarters.
  • Torray Investment Partners's Teladoc Health position peaked at $2.08M in Q3 2020.
  • 679 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Torray Investment Partners's 13F filing for Q1 2022, filed 3 May 2022.